Neuren Pharmaceuticals Ltd (NEU) — Capital Reinvestment Ratio
Neuren Pharmaceuticals Ltd (NEU) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$128.31 Million) in capital expenditures (AU$5.00K). Check NEU tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Neuren Pharmaceuticals Ltd Capital Reinvestment Ratio (2018–2023)
This chart tracks Neuren Pharmaceuticals Ltd's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see NEU cash flow metrics.
Annual Capital Reinvestment Ratio for Neuren Pharmaceuticals Ltd (2018–2023)
Year-by-year Capital Reinvestment Ratio for Neuren Pharmaceuticals Ltd from 2018 to 2023. See Neuren Pharmaceuticals Ltd (NEU) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.00x | AU$184.93 Million | AU$40.00K | ▼ -95.9% |
| 2022 | 0.01x | AU$3.60 Million | AU$19.00K | ▲ +181.9% |
| 2018 | 0.00x | AU$6.41 Million | AU$12.00K | — |